Literature DB >> 25483090

C/EBPα regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint.

Jonathan R Hall1, Michael S Bereman, Angelito I Nepomuceno, Elizabeth A Thompson, David C Muddiman, Robert C Smart.   

Abstract

The bZIP transcription factor, C/EBPα is highly inducible by UVB and other DNA damaging agents in keratinocytes. C/EBPα-deficient keratinocytes fail to undergo cell cycle arrest in G1 in response to UVB-induced DNA damage and mice lacking epidermal C/EBPα are highly susceptible to UVB-induced skin cancer. The mechanism through which C/EBPα regulates the cell cycle checkpoint in response to DNA damage is unknown. Here we report untreated C/EBPα-deficient keratinocytes have normal levels of the cyclin-dependent kinase inhibitor, p21, however, UVB-treated C/EBPα-deficient keratinocytes fail to up-regulate nuclear p21 protein levels despite normal up-regulation of Cdkn1a mRNA levels. UVB-treated C/EBPα-deficient keratinocytes displayed a 4-fold decrease in nuclear p21 protein half-life due to the increased proteasomal degradation of p21 via the E3 ubiquitin ligase CRL4(Cdt2). Cdt2 is the substrate recognition subunit of CRL4(Cdt2) and Cdt2 mRNA and protein levels were up-regulated in UVB-treated C/EBPα-deficient keratinocytes. Knockdown of Cdt2 restored p21 protein levels in UVB-treated C/EBPα-deficient keratinocytes. Lastly, the failure to accumulate p21 in response to UVB in C/EBPα-deficient keratinocytes resulted in decreased p21 interactions with critical cell cycle regulatory proteins, increased CDK2 activity, and inappropriate entry into S-phase. These findings reveal C/EBPα regulates G1/S cell cycle arrest in response to DNA damage via the control of CRL4(Cdt2) mediated degradation of p21.

Entities:  

Keywords:  C/EBPα; C/EBPα, CCAAT/enhancer binding protein α; CRL, Cullin-RING ubiquitin ligases; CRL4Cdt2; DCAF, DDB1/CUL4-associated factor; Cdt2, Cdc10 dependent transcript 2; G1/S DNA damage checkpoint; SCF, Skp, Cullin, F-box containing complex; UVB, ultraviolet B; keratinocytes, p21

Mesh:

Substances:

Year:  2014        PMID: 25483090      PMCID: PMC4614632          DOI: 10.4161/15384101.2014.962957

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  53 in total

1.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

2.  Semi-supervised learning for peptide identification from shotgun proteomics datasets.

Authors:  Lukas Käll; Jesse D Canterbury; Jason Weston; William Stafford Noble; Michael J MacCoss
Journal:  Nat Methods       Date:  2007-10-21       Impact factor: 28.547

3.  CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation.

Authors:  Hideo Nishitani; Yasushi Shiomi; Hiroka Iida; Masato Michishita; Toshihiro Takami; Toshiki Tsurimoto
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

4.  CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.

Authors:  Tarek Abbas; Etsuko Shibata; Jonghoon Park; Sudhakar Jha; Neerja Karnani; Anindya Dutta
Journal:  Mol Cell       Date:  2010-10-08       Impact factor: 17.970

5.  SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation.

Authors:  Stine Jørgensen; Morten Eskildsen; Kasper Fugger; Lisbeth Hansen; Marie Sofie Yoo Larsen; Arne Nedergaard Kousholt; Randi G Syljuåsen; Morten Beck Trelle; Ole Nørregaard Jensen; Kristian Helin; Claus Storgaard Sørensen
Journal:  J Cell Biol       Date:  2011-01-10       Impact factor: 10.539

6.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.

Authors:  Youngjo Kim; Natalia G Starostina; Edward T Kipreos
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

7.  PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex.

Authors:  Tarek Abbas; Uma Sivaprasad; Kenta Terai; Virginia Amador; Michele Pagano; Anindya Dutta
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

8.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

Authors:  J Chen; P K Jackson; M W Kirschner; A Dutta
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

Review 9.  Examination of the expanding pathways for the regulation of p21 expression and activity.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  Cell Signal       Date:  2010-01-25       Impact factor: 4.315

10.  Transcriptional regulation of an evolutionary conserved intergenic region of CDT2-INTS7.

Authors:  Hiroki Nakagawa; Moe Tategu; Rieko Yamauchi; Kaori Sasaki; Sota Sekimachi; Kenichi Yoshida
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

View more
  12 in total

Review 1.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  Characterization of basal gene expression trends over a diurnal cycle in Xiphophorus maculatus skin, brain and liver.

Authors:  Yuan Lu; Jose Reyes; Sean Walter; Trevor Gonzalez; Geraldo Medrano; Mikki Boswell; William Boswell; Markita Savage; Ronald Walter
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-12-05       Impact factor: 3.228

Review 3.  Small molecule therapeutics targeting F-box proteins in cancer.

Authors:  Yuan Liu; Rama K Mallampalli
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

4.  Induction and Validation of Cellular Senescence in Primary Human Cells.

Authors:  Alejandra Hernandez-Segura; Simone Brandenburg; Marco Demaria
Journal:  J Vis Exp       Date:  2018-06-20       Impact factor: 1.355

5.  p53 activation by Cr(VI): a transcriptionally limited response induced by ATR kinase in S-phase.

Authors:  Michal W Luczak; Casey Krawic; Anatoly Zhitkovich
Journal:  Toxicol Sci       Date:  2019-08-06       Impact factor: 4.849

Review 6.  The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications.

Authors:  Youzhou Sang; Fan Yan; Xiubao Ren
Journal:  Oncotarget       Date:  2015-12-15

7.  MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4BDCAF13 E3 Ligase in Osteosarcoma Cells.

Authors:  Zhi Chen; Wei Zhang; Kaibiao Jiang; Bin Chen; Kun Wang; Lifeng Lao; Canglong Hou; Fei Wang; Caiguo Zhang; Hongxing Shen
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-22       Impact factor: 8.886

8.  Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.

Authors:  Song Xu; Li Li; Min Li; Mengli Zhang; Mei Ju; Xu Chen; Heng Gu
Journal:  Oxid Med Cell Longev       Date:  2017-03-16       Impact factor: 6.543

9.  KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL.

Authors:  Li Zhu; Fengjun Xiao; Yue Yu; Hua Wang; Min Fang; Yuefeng Yang; Huiyan Sun; Lisheng Wang; Yuan Sheng
Journal:  Anticancer Drugs       Date:  2016-10       Impact factor: 2.248

10.  Activation of TNF-α/NF-κB axis enhances CRL4BDCAF11 E3 ligase activity and regulates cell cycle progression in human osteosarcoma cells.

Authors:  Caiguo Zhang; Bin Chen; Kaibiao Jiang; Lifeng Lao; Hongxing Shen; Zhi Chen
Journal:  Mol Oncol       Date:  2018-02-20       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.